| Cat. No. |
Product Name |
Information |
| PC-23866 |
ULTR-p38i 2015
p38α inhibitor
|
ULTR-p38i 2015 is a potent, selective type 1.5 p38α inhibitor with IC50 of 4.8 nM, specifically inhibits p38α and p38β. |
| PC-23072 |
GEn-1124
p38α/MK2 modulator
|
GEn-1124 is a first-in-class small molecule modulator of p38α/MK2 signaling targeted to a pocket near the ED substrate binding domain of p38α, destabilizes the MK2: p38 complex. |
| PC-23071 |
UM101
p38α inhibitor
|
UM101 is a specific, noncatalytic, substrate-selective p38α MAPK inhibitor, targest the ED substrate-docking site and exerts anti-inflammatory effects. |
| PC-21600 |
BMS-582949
p38 MAPK inhibitor
|
BMS-582949 is a potent, selective and orally active p38α MAP kinase inhibitor with IC50 of 13 nM, exhibits significant inhibition of TNFα release in hPBMC with IC50 of 50 nM. |
| PC-21599 |
Dilmapimod
p38 MAPK inhibitor
|
SB-681323 is a potent and selective p38 MAPK inhibitor, potentially suppresses inflammation in chronic obstructive pulmonary disease. |
| PC-20954 |
NC-p38i NC-37
p38α inhibitor
|
Non-canonical p38α inhibitor NC-37 (NC-p38i NC-37) is a potent, highly selective, non-canonical inhibitor of p38α, inhibits TAB1-induced p38α autophosphorylation in vitro with IC50 of 0.27 uM. |
| PC-49694 |
VCP979
p38 MAPK inhibitor
|
VCP979 (VCP-979) is a novel selective small molecule p38 MAPK inhibitor with a significantly greater affinity for the active form of p38 MAPK, has significant anti-fibrotic effects in vitro and in vivo. |
| PC-42492 |
SB 203580 hydrochloride
|
A specific p38 MAPK inhibitor with IC50 of 0.6 uM. |
